Literature DB >> 28668223

An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy.

Srinivasa Reddy Bonam1, Charalambos D Partidos2, Sampath Kumar M Halmuthur3, Sylviane Muller4.   

Abstract

Adjuvants incorporated in prophylactic and/or therapeutic vaccine formulations impact vaccine efficacy by enhancing, modulating, and/or prolonging the immune response. In addition, they reduce antigen concentration and the number of immunizations required for protective efficacy, therefore contributing to making vaccines more cost effective. Our better understanding of the molecular mechanisms of immune recognition and protection has led research efforts to develop new adjuvants that are currently at various stages of development or clinical evaluation. In this review, we focus mainly on several of these promising adjuvants, and summarize recent work conducted in various laboratories to develop novel lipid-containing adjuvants.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CpG ODNs; QS-21; delivery systems; lipopeptides; new adjuvants; patents; vaccines

Mesh:

Substances:

Year:  2017        PMID: 28668223     DOI: 10.1016/j.tips.2017.06.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  66 in total

1.  Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction.

Authors:  Zongmin Zhao; Brian Harris; Yun Hu; Theresa Harmon; Paul R Pentel; Marion Ehrich; Chenming Zhang
Journal:  Biomaterials       Date:  2017-11-20       Impact factor: 12.479

2.  Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.

Authors:  Yoshifumi Kimizuka; Wataru Katagiri; Joseph J Locascio; Ayako Shigeta; Yuri Sasaki; Mai Shibata; Kaitlyn Morse; Ruxandra F Sîrbulescu; Mizuki Miyatake; Patrick Reeves; Makoto Suematsu; Jeffrey Gelfand; Timothy Brauns; Mark C Poznansky; Kosuke Tsukada; Satoshi Kashiwagi
Journal:  J Immunol       Date:  2018-11-12       Impact factor: 5.422

Review 3.  A review of innate and adaptive immunity to coccidioidomycosis.

Authors:  Chiung-Yu Hung; Amy P Hsu; Steven M Holland; Joshua Fierer
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

4.  Laser adjuvant for vaccination.

Authors:  Satoshi Kashiwagi
Journal:  FASEB J       Date:  2020-01-28       Impact factor: 5.191

Review 5.  Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies.

Authors:  Shetal A Patel; Andy J Minn
Journal:  Immunity       Date:  2018-03-20       Impact factor: 31.745

6.  STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice.

Authors:  Ross J Darling; Sujata Senapati; Sean M Kelly; Marian L Kohut; Balaji Narasimhan; Michael J Wannemuehler
Journal:  Vaccine       Date:  2019-04-12       Impact factor: 3.641

Review 7.  Bioinspired nucleic acid structures for immune modulation.

Authors:  Cameron Louttit; Kyung Soo Park; James J Moon
Journal:  Biomaterials       Date:  2019-06-19       Impact factor: 12.479

8.  Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response.

Authors:  Chengcheng Song; Xiu-Jing Zheng; Haili Guo; Yafei Cao; Fan Zhang; Qin Li; Xin-Shan Ye; Yifa Zhou
Journal:  Glycoconj J       Date:  2019-07-02       Impact factor: 2.916

9.  A novel vaccine adjuvant based on straight polyacrylate potentiates vaccine-induced humoral and cellular immunity in cynomolgus macaques.

Authors:  Vincent Pavot; Hélène Bisceglia; Florine Guillaume; Sandrine Montano; Linong Zhang; Florence Boudet; Jean Haensler
Journal:  Hum Vaccin Immunother       Date:  2021-01-10       Impact factor: 3.452

Review 10.  Chikungunya Virus Vaccines: Platforms, Progress, and Challenges.

Authors:  Victor R DeFilippis
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.